Adjusted earnings beat estimates; guidance held, but hedges obscured weaker core profit.

The quarter beat the published bar, especially on adjusted EPS. Adjusted diluted EPS was $1.13 versus a published consensus near $0.90, while oil and gas sales reached $670.8 million versus an external revenue expectation near $568 million. The reported $2.19 GAAP EPS was inflated by a $156.5 million unrealized derivative gain, so adjusted earnings are the cleaner comparison. (Non-GAAP Financial Measures) (Income Statement)

The operating result was solid, but not as strong as the headline earnings beat suggests. Production grew 9% year over year to 145,659 Boe per day despite roughly 7,000 Boe per day of temporary shut-ins, and lease operating costs improved to $9.59 per Boe from $9.95. However, adjusted EBITDA fell 9% year over year to $401.0 million and adjusted diluted EPS fell from $1.37 to $1.13, reflecting unfavorable realized hedge results, higher G&A, and a larger share count. (Production and Average Sales Prices) (Non-GAAP Financial Measures)

Hedging was the main distortion in the quarter. Unhedged realized commodity pricing improved 24% per Boe, but settled derivatives produced an $86.3 million cash loss, reducing realized price including derivatives to $44.10 per Boe from $45.86 a year earlier. The $156.5 million mark-to-market gain boosted GAAP results but is non-cash and does not represent current-period operating cash generation. (Average Sales Prices) (Commodity Derivatives)

The outlook was maintained rather than upgraded. Full-year production, oil volumes, capital spending of $850 million–$900 million, and wells turned in line were unchanged. The modest guidance improvements were limited to the lower end of lease operating costs, a narrower oil differential, and a higher gas-realization range. That is better than a cut, but it does not raise the earnings runway beyond what investors already had. (Revised FY 2026 Guidance)

Capital allocation was shareholder-friendly but came with higher leverage and acquisition exposure. NOG repurchased 2.95 million shares, about 3% of outstanding stock, at an average $20.37 and increased remaining repurchase capacity to approximately $243 million. At the same time, non-budgeted acquisitions totaled $261.0 million, long-term debt rose to $2.72 billion from $2.40 billion at year-end, and the Duvernay expansion added transaction costs. Free cash flow of $159.0 million covered budgeted capital spending, but the broader acquisition program remains debt-intensive. (Capital Expenditures and Acquisition Activity) (Balance Sheet) (Free Cash Flow)

Net: a real but qualified beat. The filing lands better than the published quarterly expectation on adjusted EPS and revenue, while production and cost execution were healthy. The qualification is that underlying adjusted profitability declined year over year, guidance was merely reaffirmed, and the headline GAAP gain relied heavily on derivatives. That supports a narrowly positive read versus expectations, not a broad upgrade to the business outlook.